On this episode of The Beat, recorded onsite at ViVE 2022, Kabir joins hosts Dr. Gautam Gulati and Dr. Jordan Shlain to discuss how the healthcare system is changing and his view on how Otsuka fits into the spectrum of mental health treatment innovation. They look at the move from mental illness to mental wellness through the utilization of technology and data for earlier interventions. Listen as Kabir shares about how Otsuka is utilizing partnerships for technological advances to push at the edges of what can be different for future mental health treatments.
Getting a patient through a mental illness is much more complex than finding the right pharmaceuticals.
But how do we develop technological solutions for earlier stage intervention and treatment options while protecting patient privacy?
Kabir Nath was the President & CEO of Otsuka North America, a pharmaceutical manufacturer based in Princeton, New Jersey. Since recording, he has recently transitioned into a global role as the the Senior Managing Director, Global Pharmaceutical Business of Otsuka. Throughout his career, Kabir has shaped strategy to deliver results in complex, challenging business environments at the country, regional and global level. At Otsuka, a 101-year-old Japanese company with a blend of Japanese and American cultures, Kabir puts his purpose into practice daily.
On this episode, Kabir joins hosts Dr. Gautam Gulati and Dr. Jordan Shlain to discuss how the healthcare system is changing and his view on how Otsuka fits into the spectrum of mental health treatment innovation. They look at the move from mental illness to mental wellness through the utilization of technology and data for earlier interventions.
Listen as Kabir shares about how Otsuka is utilizing partnerships for technological advances to push at the edges of what can be different for future mental health treatments.
Topics Covered
Connect with Kabir Nath
Connect with Dr. Gautam Gulati, Dr. Jordan Shlain, & Dr. Jessica Shepherd
Resources